Spermine-Decorated Microbubbles for High Drug Loading
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug delivery methods face challenges in achieving high drug/carrier loading efficiencies, stable loading, protection of therapeutic agents from biodegradation, targeting specific tissues and cell types, and efficient uptake of drugs, particularly with viral vectors used in gene therapy which are limited by mutagenesis and immunogenicity, and microbubbles show weak and unstable binding to payloads like DNA with concerns about toxicity.
Innovation Solution
Development of microbubble compositions with spermine-decorated microbubbles, where spermine molecules are associated with the external surface via interlinking polymers like dextran, allowing for effective binding and delivery of nucleic acids or other pharmaceuticals across cell membranes using sonoporation techniques, with optional targeting molecules for spatial and temporal control.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral vectors are used for gene therapy delivery, then high drug loading efficiency is achieved, but mutagenesis and immunogenicity occur
Solution Approach 1:
The patent uses microbubbles as an intermediary carrier between the therapeutic agent and target cells. The microbubble surface is decorated with spermine molecules that mediate the binding and delivery of nucleic acids, replacing viral vectors as the delivery vehicle to avoid immunogenicity while maintaining high loading efficiency
Solution Approach 2:
The patent changes the chemical parameters of the microbubble surface by decorating it with spermine molecules, which have specific electrostatic properties that enable high-capacity binding of negatively charged nucleic acids. This parameter change allows achieving high drug loading without the harmful effects of viral vectors
2Object-affected harmful factors
If microbubbles are used for drug delivery, then low toxicity is achieved, but weak and unstable binding to payloads occurs
Solution Approach 1:
The patent applies local quality modification by decorating only the external surface of the microbubble with spermine molecules, rather than changing the entire microbubble structure. This localized modification enhances payload binding stability while preserving the low toxicity of the base microbubble structure
Solution Approach 2:
The patent creates a composite structure by combining microbubbles with spermine molecules on the surface. This composite material integrates the low toxicity of microbubbles with the high binding affinity of spermine, achieving both low toxicity and stable payload binding
3Quantity of substance
If large amounts of spermine molecules are associated with microbubbles via interlinking polymers, then high payload loading is achieved, but device complexity increases
Solution Approach 1:
The patent segments the complex delivery system into distinct functional modules: microbubbles as the core carrier, spermine molecules as the binding agents on the surface, and interlinking polymers as the structural framework. This segmentation allows high payload loading while managing complexity through modular design
Solution Approach 2:
The interlinking polymers serve multiple functions: they provide structural support for attaching spermine molecules, enable high-density packing of spermine on the microbubble surface, and facilitate payload binding. This multi-functionality achieves high payload loading without proportionally increasing system complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microbubble compositions enable efficient and stable loading of large amounts of payload onto microbubbles, enhancing bioavailability and targeting specificity, while minimizing toxicity and improving cellular uptake, thereby overcoming limitations of existing drug delivery methods.
Implementation Method 1
The external surface of the microbubble compositions may be decorated with spermine molecules for effectively binding to a payload
Implementation Method 2
The payload may be effectively delivered across cell membranes in a spatially and temporally targeted manner using sonoporation techniques
Data Source
AI summary
Spermine-decorated microbubbles and methods of making the same as well as methods for using spermine-decorated microbubbles for drug delivery are described.